Search

everythinglearnresearchcommunity

for

Search:↓

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Oral finasteride and dutasteride may negatively affect erectile function in rats.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

The document concludes that women should not use 5-alpha-reductase inhibitors due to the risk of birth defects and limited effectiveness.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

Certain Dibenzo derivatives may help treat prostate cancer.

Medicines called 5-alpha-reductase inhibitors, like finasteride and dutasteride, are useful for treating enlarged prostate and male pattern hair loss.

Taking 5 alpha reductase inhibitor medication slightly increases the risk of depression, especially as you get older.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

The dutasteride nanoemulsion could improve hair loss treatment by enhancing drug penetration and retention in hair follicles.

Finasteride, when given in high oral doses to pregnant monkeys, caused genital abnormalities in male fetuses, but not in female fetuses or those exposed to intravenous finasteride.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

5-alpha reductase inhibitors are generally safe but can cause sexual side effects and require patient education on risks.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

Accurate protein modeling can help develop new treatments for prostate cancer and other diseases.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

Long-term use of a drug for hair loss and prostate issues can cause metabolic problems and depression-like behavior in young male rats.

Finasteride may help reduce anxiety and depression in elderly but might cause depression in young men.

Finasteride 5mg daily is the most effective for female pattern hair loss, with higher doses of treatments generally more effective.

Testosterone undecanoate safely and effectively increased penis size in male children with 5-alpha-reductase deficiency.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Using finasteride or dutasteride does not increase the risk of male breast cancer.